Cargando…
Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis
Neuroblastoma is a pediatric malignancy of the sympathetic ganglia and adrenal glands, hypothesized to originate from progenitors of the developing sympathetic nervous system. Amplification of the MYCN oncogene is a genetic marker of risk in this disease. Understanding the impact of oncogene express...
Autores principales: | Mobley, Bret C., Kwon, Minjae, Kraemer, Bradley R., Hickman, F. Edward, Qiao, Jingbo, Chung, Dai H., Carter, Bruce D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519318/ https://www.ncbi.nlm.nih.gov/pubmed/26222553 http://dx.doi.org/10.1371/journal.pone.0133897 |
Ejemplares similares
-
Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development
por: Yuan, Ye, et al.
Publicado: (2023) -
Lineage-restricted sympathoadrenal progenitors confer neuroblastoma origin and its tumorigenicity
por: Yang, Chia-Lung, et al.
Publicado: (2020) -
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
por: Nagy, Zsuzsanna, et al.
Publicado: (2021) -
Attenuation of sympathoadrenal responses and anesthetic requirement by dexmedetomidine
por: Laha, Arpita, et al.
Publicado: (2013) -
p57Kip2 regulates embryonic blood stem cells by controlling sympathoadrenal progenitor expansion
por: Kapeni, Chrysa, et al.
Publicado: (2022)